Stay updated with breaking news from Jason Gotlib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Gotlib discusses the significance of the FDA approval of avapritinib in indolent systemic mastocytosis, key findings from the PIONEER trial, and the quality of life benefits that avapritinib provides for patients in this population.
Systemic mastocytosis is widely underdiagnosed, and many more hematologic oncologists should be looking for it, say experts.
/PRNewswire/ -- The Mizzou New Music Initiative will welcome Meredith Monk and Angélica Negrón (both pictured below) as distinguished guest composers at the...